Biotechnology holds enormous promise for medicine, agriculture, and industry, but it also carries security risks that governments are only beginning to address. Advances in synthetic biology and the life sciences raise questions of safety, competitiveness, and the potential for misuse. This hub follows the strategic dimension of the field: biosecurity and biodefense, the biotech competition for leadership in the bioeconomy, the protection of sensitive research in synthetic biology, and the governance frameworks needed to manage dual-use research. The biotech competition between democracies and authoritarian states is intensifying, and research security is now central to it. Fellows and analysts assess how democracies can capture the benefits of the bioeconomy while guarding against its dangers. Explore analysis and commentary on biotechnology, biosecurity, and the policies shaping the life sciences.
Biotechnology
Western engagement with Chinese biotech is accelerating. It’s dangerous.
No Result Found
July 31, 2026
The West Must Confront China’s Biotech Offensive
Western engagement with Chinese biotech is accelerating. It’s dangerous.
April 13, 2026
The New National Security Risk: Biotech
Both the US and Europe are embedding biotech data into national security policy.
February 27, 2026
Kiana Aran on AI & the Future of Biotech
Scientific innovator Kiana Aran breaks down the new biotech frontier and the growing role of technology and science in geopolitics.
November 19, 2025
The New China Challenge: Gene Editing on the Farm
The US and Europe deem gene editing of crops a national security priority.
October 20, 2025
Biotech Battle: US Legislators Go On the Offensive
Congress is accelerating a proactive biotech agenda. The US and Europe must work together to beat China.
August 7, 2025
Biotech Blues: The West Struggles To Stay Ahead
China is challenging American and European leadership in biotech and AI-driven medicine.